---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-303045"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2021-10-20T23:59:59+00:00"
generated_at: "2026-06-28T19:44:09.837356+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics files amended charter post-IPO, authorizing 150M common and 5M preferred shares

## Summary
- Amended charter and bylaws became effective upon IPO closing on October 19, 2021.
- Authorized capital: 150,000,000 shares of common stock, par value $0.00001 per share.
- Authorized capital includes 5,000,000 shares of preferred stock.
- Charter and bylaws are in the form previously filed with the Registration Statement on Form S-1.
- No other material modifications to security holder rights were reported.

## SEC filing metadata
- accession: 0001193125-21-303045
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2021-10-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000119312521303045/0001193125-21-303045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000119312521303045/d134002d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-303045
- JSON: https://secwatch.observer/filing/0001193125-21-303045.json
- Plain text: https://secwatch.observer/filing/0001193125-21-303045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.